Insurance Churn Linked to Worse Diabetes Control in Community Health Center Patients

Insurance churn—defined as losing coverage for multiple medical visits—was associated with near-term worsening in diabetes measures among low-income adults receiving care at community health centers, according to research from Oregon Health & Science University. Investigators linked coverage loss to a directionally worse pattern of blood sugar control than was seen in patients who remained insured. The report also described a concurrent shift toward more intensive pharmacotherapy among those who lost coverage, with overall glycemic control described as worse in this population after insurance loss.

The analysis was an observational study using electronic health records from community health centers, drawing on clinics across 20 states and including more than 39,000 adults with diabetes. These clinics largely serve people living in or near poverty, positioning the cohort as a low-income population often affected by coverage instability. For comparison, the report describes patients who lost insurance as being evaluated against others who were “nearly identical” at baseline and who remained insured.

The study reported poorer blood sugar control among patients who experienced insurance loss, alongside greater use of higher-intensity diabetes therapies relative to those who stayed insured. It specifically described increases in insulin use and other high-intensity treatments in the group that lost coverage.

Serious diabetes-related complications were described as less common during the study period, contrasted with the reported near-term changes in glycemic control and treatment intensity. This pattern may relate, at least in part, to limited follow-up time, with serious outcomes framed as events that may not occur “overnight.” Examples cited in that context included amputations and kidney failure. The authors cautioned against over-interpreting complication patterns given the follow-up window available in the analysis.

The reporting also described the operational context of community health centers, noting that these clinics may offer discounted medications while relying heavily on Medicaid funding. The authors raised concern that shrinking coverage could strain clinic capacity to care for patients who lose insurance, particularly when treatment becomes more complex and harder to afford without coverage. The report also included statements emphasizing affordability challenges for insulin without insurance.